News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China Nuokang Bio-Pharmaceutical Inc. (NKBP) Announces Change in CFO



6/15/2012 9:20:40 AM

BEIJING, June 15, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that Robert Tianruo Pu, the chief financial officer of the Company, has tendered his resignation for personal reasons, effective June 30, 2012. Felix Chungfai Wong, currently the Company's finance director, will replace Mr. Pu to serve as the chief financial officer. Upon his resignation, Mr. Pu will remain with the Company as a consultant.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES